3.750SEK-0.27%Mkt Cap: 13.93M $P/E: —1d ago
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap13.93M $
Enterprise Value33.39M $
Revenue (TTM)45.76M $
Gross Profit20.45M $
Net Income (TTM)-358.98K $
Revenue/Share1.176 USD
Last Price3.750 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees200
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)3.32
PEG—
EV/EBITDA7.10
EV/Revenue0.73
P/S0.30
P/B0.85
EPS (TTM)-0.03
EPS (Forward)1.13
52W Range
3.0909% of range10.60
52W High10.60 SEK
52W Low3.090 SEK
Profitability
Gross Margin43.66%
Oper. Margin-1.38%
EBITDA Margin10.27%
Profit Margin-0.77%
ROE-2.24%
ROA-0.80%
Growth
Revenue Growth-10.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF79.30K $
CapEx (TTM)474.72K $
FCF Margin3.86%
FCF Yield12.67%
Net Debt19.47M $
Net Debt/EBITDA4.14
Balance Sheet
Debt/Equity1.33
Current Ratio1.06
Quick Ratio0.69
Book Value/Sh4.416 SEK
Cash/Share0.4760 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield0.73%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date—
Splits
Last Split4:1
Split DateJun 1, 2018
Analyst Consensus
Rating—
Target (Mean)3.800 SEK
Upside (mean)+1.3%
Target Range3.800 SEK – 3.800 SEK
# Analysts1
Ownership
Shares Out.38.83M
Float22.80M
Insiders35.31%
Institutions54.43%
Technical
SMA 503.463 (+8.3%)
SMA 2004.489 (-16.5%)
Beta0.18
S&P 52W Chg19.63%
Avg Vol (30d)24.23K
Avg Vol (10d)27.42K
Technical Indicators
RSI (14)55.4
MACD0.1015
MACD Signal0.1044
MACD Hist.-0.0030
BB Upper4.123 SEK
BB Middle3.674 SEK
BB Lower3.224 SEK
BB Width24.45%
ATR (14)0.1738 SEK
Vol Ratio (20d)0.25x